171 related articles for article (PubMed ID: 18629495)
21. Prolonged, NK cell-mediated antitumor effects of suicide gene therapy combined with monocyte chemoattractant protein-1 against hepatocellular carcinoma.
Tsuchiyama T; Nakamoto Y; Sakai Y; Marukawa Y; Kitahara M; Mukaida N; Kaneko S
J Immunol; 2007 Jan; 178(1):574-83. PubMed ID: 17182598
[TBL] [Abstract][Full Text] [Related]
22. Treatment of murine hepatocellular carcinoma using genetically modified cells to express interleukin-12.
Peron JM; Couderc B; Rochaix P; Douin-Echinard V; Asnacios A; Souque A; Voigt JJ; Buscail L; Vinel JP; Favre G
J Gastroenterol Hepatol; 2004 Apr; 19(4):388-96. PubMed ID: 15012775
[TBL] [Abstract][Full Text] [Related]
23. Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity.
Suzuki E; Kapoor V; Jassar AS; Kaiser LR; Albelda SM
Clin Cancer Res; 2005 Sep; 11(18):6713-21. PubMed ID: 16166452
[TBL] [Abstract][Full Text] [Related]
24. Natural killer cells produce T cell-recruiting chemokines in response to antibody-coated tumor cells.
Roda JM; Parihar R; Magro C; Nuovo GJ; Tridandapani S; Carson WE
Cancer Res; 2006 Jan; 66(1):517-26. PubMed ID: 16397268
[TBL] [Abstract][Full Text] [Related]
25. (2S)-2′-methoxykurarinone from Sophora flavescens suppresses cutaneous T cell-attracting chemokine/CCL27 expression induced by interleukin-ß/tumor necrosis factor-α via heme oxygenase-1 in human keratinocytes.
Jeong SI; Lee YE; Jang SI
J Med Food; 2010 Oct; 13(5):1116-24. PubMed ID: 20883179
[TBL] [Abstract][Full Text] [Related]
26. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
27. Intratumoral expression of MIP-1beta induces antitumor responses in a pre-established tumor model through chemoattracting T cells and NK cells.
Luo X; Yu Y; Liang A; Xie Y; Liu S; Guo J; Wang W; Qi R; An H; Zhang M; Xu H; Guo Z; Cao X
Cell Mol Immunol; 2004 Jun; 1(3):199-204. PubMed ID: 16219168
[TBL] [Abstract][Full Text] [Related]
28. Expression and regulation in the brain of the chemokine CCL27 gene locus.
Gunsolly C; Nicholson JD; Listwak SJ; Ledee D; Zelenka P; Verthelyi D; Chapoval S; Keegan A; Tonelli LH
J Neuroimmunol; 2010 Aug; 225(1-2):82-90. PubMed ID: 20605223
[TBL] [Abstract][Full Text] [Related]
29. Cytokine gene therapy using adenovirally transduced, tumor-seeking activated natural killer cells.
Goding SR; Yang Q; Knudsen KB; Potter DM; Basse PH
Hum Gene Ther; 2007 Aug; 18(8):701-11. PubMed ID: 17678438
[TBL] [Abstract][Full Text] [Related]
30. An investigation of adverse effects caused by the injection of high-dose TNFalpha-expressing adenovirus vector into established murine melanoma.
Okada Y; Okada N; Mizuguchi H; Hayakawa T; Mayumi T; Mizuno N
Gene Ther; 2003 Apr; 10(8):700-5. PubMed ID: 12692598
[TBL] [Abstract][Full Text] [Related]
31. IL-12 enhances the antitumor actions of trastuzumab via NK cell IFN-γ production.
Jaime-Ramirez AC; Mundy-Bosse BL; Kondadasula S; Jones NB; Roda JM; Mani A; Parihar R; Karpa V; Papenfuss TL; LaPerle KM; Biller E; Lehman A; Chaudhury AR; Jarjoura D; Burry RW; Carson WE
J Immunol; 2011 Mar; 186(6):3401-9. PubMed ID: 21321106
[TBL] [Abstract][Full Text] [Related]
32. Enhanced antitumor effect and reduced vector dissemination with fiber-modified adenovirus vectors expressing herpes simplex virus thymidine kinase.
Mizuguchi H; Hayakawa T
Cancer Gene Ther; 2002 Mar; 9(3):236-42. PubMed ID: 11896439
[TBL] [Abstract][Full Text] [Related]
33. Role of NK and T cells in IL-12-induced anti-tumor response against hepatic colon carcinoma.
Pham-Nguyen KB; Yang W; Saxena R; Thung SN; Woo SL; Chen SH
Int J Cancer; 1999 May; 81(5):813-9. PubMed ID: 10328238
[TBL] [Abstract][Full Text] [Related]
34. Adenoviral vectors stimulate murine natural killer cell responses and demonstrate antitumor activities in the absence of transgene expression.
Ruzek MC; Kavanagh BF; Scaria A; Richards SM; Garman RD
Mol Ther; 2002 Feb; 5(2):115-24. PubMed ID: 11829518
[TBL] [Abstract][Full Text] [Related]
35. Intratumoral expression of respiratory syncytial virus fusion protein in combination with cytokines encoded by adenoviral vectors as in situ tumor vaccine for colorectal cancer.
Hoffmann D; Bayer W; Grunwald T; Wildner O
Mol Cancer Ther; 2007 Jul; 6(7):1942-50. PubMed ID: 17620425
[TBL] [Abstract][Full Text] [Related]
36. Adenovirus-mediated expression of interleukin-12 induces natural killer cell activity and complements adenovirus-directed gp75 treatment of melanoma lung metastases.
Hirschowitz EA; Crystal RG
Am J Respir Cell Mol Biol; 1999 May; 20(5):935-41. PubMed ID: 10226063
[TBL] [Abstract][Full Text] [Related]
37. Immunomodulatory gene therapy with interleukin 12 and 4-1BB ligand: long- term remission of liver metastases in a mouse model.
Martinet O; Ermekova V; Qiao JQ; Sauter B; Mandeli J; Chen L; Chen SH
J Natl Cancer Inst; 2000 Jun; 92(11):931-6. PubMed ID: 10841829
[TBL] [Abstract][Full Text] [Related]
38. Attenuation of the glucocorticoid response during Ad5IL-12 adenovirus vector treatment enhances natural killer cell-mediated killing of MHC class I-negative LNCaP prostate tumors.
Raja Gabaglia C; Diaz de Durana Y; Graham FL; Gauldie J; Sercarz EE; Braciak TA
Cancer Res; 2007 Mar; 67(5):2290-7. PubMed ID: 17332360
[TBL] [Abstract][Full Text] [Related]
39. IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34
Van der Meer JMR; Maas RJA; Guldevall K; Klarenaar K; de Jonge PKJD; Evert JSH; van der Waart AB; Cany J; Safrit JT; Lee JH; Wagena E; Friedl P; Önfelt B; Massuger LF; Schaap NPM; Jansen JH; Hobo W; Dolstra H
Cancer Immunol Immunother; 2021 May; 70(5):1305-1321. PubMed ID: 33140189
[TBL] [Abstract][Full Text] [Related]
40. Intratumoral hu14.18-IL-2 (IC) induces local and systemic antitumor effects that involve both activated T and NK cells as well as enhanced IC retention.
Yang RK; Kalogriopoulos NA; Rakhmilevich AL; Ranheim EA; Seo S; Kim K; Alderson KL; Gan J; Reisfeld RA; Gillies SD; Hank JA; Sondel PM
J Immunol; 2012 Sep; 189(5):2656-64. PubMed ID: 22844125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
